Forbes Medi-Tech




Previous All pages Next 1 2 3 4 Page 5 6 7 8 9
March 31, 2006  Forbes Medi-Tech Announces Change in Board of Directors
March 30, 2006  Forbes Medi-Tech announces Financial Results for the Year ended December 31, 2005
March 29, 2006  Forbes Medi-Tech Announces Timing of Year End Financial Results
March 23, 2006  Forbes Medi-Tech Provides 2006 Outlook for Ingredient Sales, Including Reducol(tm)
March 14, 2006  Forbes Medi-Tech Announces Completion of Phyto-Source Sale and Receipt of Funds
February 28, 2006  Forbes Medi-Tech Announces Launch of Cholesterol-Lowering Milk Drink with Reducol(tm) at Tesco Stores Ltd.
February 23, 2006  Forbes Medi-Tech Agrees To Sell Sterol Manufacturing Interest for US$25 million and Signs 5 Year Supply Agreement for Reducol(tm)
February 13, 2006  Forbes Medi-Tech Announces Pharmavite Contract Renewal
February 10, 2006  Forbes Medi-Tech Inc. to Present at BIO CEO & Investor Conference
January 23, 2006  Forbes Medi-Tech Announces Extension of Major Sterol Supply Agreement
January 04, 2006  Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd
December 20, 2005  Forbes Medi-Tech Launches Cholesterol-Lowering Ingredient Reducol(tm) in the UK
December 02, 2005  Forbes Medi-Tech Initiates Dosing Phase in Clinical Trial for Cholesterol-Lowering Drug, FM-VP4
November 14, 2005  Forbes Medi-Tech Announces Third Quarter 2005 Financial Results
November 11, 2005  Forbes Medi-Tech Announces Timing of Third Quarter Financial Results
November 03, 2005  Forbes Medi-Tech to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference
November 02, 2005  Forbes Medi-Tech Initiates US Phase II Trial for Cholesterol-Lowering Drug, FM-VP4
October 27, 2005  Forbes Medi-Tech Completes US$6 Million Private Placement
October 03, 2005  Forbes Medi-Tech Receives FDA Clearance to Initiate US Phase II Trial for Cholesterol-Lowering Drug, FM-VP4
September 28, 2005  Phyto-Source Manufacturing Facility Remains Intact After Hurricane Rita
September 15, 2005  Forbes Medi-Tech Preclinical Study Results Demonstrate Cholesterol-Lowering Effects of FM-VP4/Statin (Zocor(r)) Combination and Effects on Obesity~
September 14, 2005  ~Forbes Medi-Tech to Present at Merriman Curhan Ford & Co. Investor Summit~
August 31, 2005  Forbes Medi-Tech Submits IND Application for Cholesterol-Lowering Drug, FM-VP4
August 23, 2005  Forbes Medi-Tech Makes Valuable Addition to the Board of Directors
August 11, 2005  Forbes Medi-Tech Announces 112% Increase in Second Quarter 2005 Revenue
Previous All pages Next 1 2 3 4 Page 5 6 7 8 9